This article summarizes recent broker commentary and news affecting several major companies including BridgeBio Pharma, DoorDash, Nvidia, and Rio Tinto. Key updates include BridgeBio Pharma’s positive Phase 3 results, analyst expectations for DoorDash’s earnings, UBS raising Nvidia’s price target, and accelerated activity at Rio Tinto’s Simandou iron ore project. It also covers other market movements, earnings reports, and analyst ratings for various companies across different sectors.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
BridgeBio Pharma, DoorDash, Nvidia, Rio Tinto: What brokers said this week
This article summarizes recent broker commentary and news affecting several major companies including BridgeBio Pharma, DoorDash, Nvidia, and Rio Tinto. Key updates include BridgeBio Pharma’s positive Phase 3 results, analyst expectations for DoorDash’s earnings, UBS raising Nvidia’s price target, and accelerated activity at Rio Tinto’s Simandou iron ore project. It also covers other market movements, earnings reports, and analyst ratings for various companies across different sectors.